BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Biodexa Announces Successful Appeal of Nasdaq Delisting

  October 15, 2024

   · 

  4 min read
• Press Releases

  The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  October 15, 2024

   · 

  2 min read
• Business

  TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024

  October 15, 2024

   · 

  1 min read
• Press Releases

  PharmAust affirms corporate strategy with name change to Neurizon Therapeutics

  October 15, 2024

   · 

  3 min read
• Business

  Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024

  October 15, 2024

   · 

  1 min read
• Press Releases

  Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago

  October 15, 2024

   · 

  2 min read
• Press Releases

  RevOpsis Therapeutics Awarded $1.8M NEI SBIR Grant to Advance R&D for Groundbreaking Ophthalmic Therapies

  October 15, 2024

   · 

  3 min read
• Press Releases

  Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions

  October 15, 2024

   · 

  6 min read
• Press Releases

  Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  October 15, 2024

   · 

  2 min read
• News

  Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

  October 15, 2024

   · 

  1 min read